St George’s, University of London Department of Oncology shows evidence that cannabinoids kill leukemia cells when combined with chemotherapy.
New study conducted by Dr. Saul Garza Morales of Mexico concludes with results showing effectiveness of RSHO-X CBD treating childhood epilepsy.
Australia is becoming a hot spot for cannabis research. Recently, the world’s first clinical trial of cannabis for cancer began thanks to Chris O’Brein Lifehouse and the University of Sidney. The trial will test whether or not cannabis has an effect on chemotherapy-induced nausea and vomiting in 80 patients. Now, researchers in Perth are turning…
As the first comprehensive study to be conducted by a Federally sanctioned institution, the NAS study has potential to expose the fallacy of the classification of cannabis as a Schedule 1 controlled substance.
This study indicates likelihood that autocatalytic inflammatory response within nerve cells can be blocked by the activation of cannabinoid receptors.
This review centers on mechanisms by which CBD inhibits tumor cell viability, invasion, metastasis, angiogenesis and cancer stem cells.
Increasing evidence suggests that use of cannabinoids as a new therapeutic target has been recommended as a promising therapy for Parkinson’s disease.